Zongmei Zhou

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 29, 2025
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.

Canjun Li, Xin Wang, Lei Deng

|Oct 23, 2024
Implementing the optimized hippo-avoidance prophylactic cranial irradiation for limited-stage small cell lung cancer by tomotherapy and volumetric modulated arc therapy.

Tian-You Zhan, Lei Deng, Wen-Qing Wang

|Apr 22, 2022
Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: A single-center experience of 85 cases.

Linfang Wu, Shijun Zhao, Hui Huang

|Mar 29, 2022
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma.

Yirui Zhai, Bo Chen, Xiaoli Feng

|Dec 20, 2021
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy.

Yufan Yang, Tao Zhang, Zongmei Zhou

|May 05, 2021
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.

Chen Li, Lijun Tan, Xiao Liu

Pageof 1

Frequent Collaborators

3 joint publications

Lei Deng

2 joint publications

Tao Zhang

2 joint publications

Qinfu Feng

2 joint publications

Zhouguang Hui